PhiChem Balance Sheet Health
Financial Health criteria checks 5/6
PhiChem has a total shareholder equity of CN¥4.1B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 37.1%. Its total assets and total liabilities are CN¥6.4B and CN¥2.3B respectively. PhiChem's EBIT is CN¥309.2M making its interest coverage ratio -10.4. It has cash and short-term investments of CN¥1.2B.
Key information
37.1%
Debt to equity ratio
CN¥1.52b
Debt
| Interest coverage ratio | -10.4x |
| Cash | CN¥1.20b |
| Equity | CN¥4.10b |
| Total liabilities | CN¥2.30b |
| Total assets | CN¥6.40b |
Recent financial health updates
PhiChem (SZSE:300398) Seems To Use Debt Quite Sensibly
Nov 20
Is PhiChem (SZSE:300398) Using Too Much Debt?
May 25Recent updates
Subdued Growth No Barrier To PhiChem Corporation (SZSE:300398) With Shares Advancing 26%
Dec 02PhiChem (SZSE:300398) Seems To Use Debt Quite Sensibly
Nov 20Optimistic Investors Push PhiChem Corporation (SZSE:300398) Shares Up 58% But Growth Is Lacking
Oct 08PhiChem's (SZSE:300398) Soft Earnings Are Actually Better Than They Appear
Sep 05PhiChem Corporation's (SZSE:300398) Price In Tune With Earnings
Aug 21PhiChem (SZSE:300398) Could Be Struggling To Allocate Capital
Jul 23Is PhiChem (SZSE:300398) Using Too Much Debt?
May 25PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%
Apr 18PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The Company
Mar 04Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)
Feb 26Financial Position Analysis
Short Term Liabilities: 300398's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥1.6B).
Long Term Liabilities: 300398's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥703.9M).
Debt to Equity History and Analysis
Debt Level: 300398's net debt to equity ratio (8%) is considered satisfactory.
Reducing Debt: 300398's debt to equity ratio has increased from 29.9% to 37.1% over the past 5 years.
Debt Coverage: 300398's debt is well covered by operating cash flow (37.7%).
Interest Coverage: 300398 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 17:39 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PhiChem Corporation is covered by 12 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tai Ma | Changjiang Securities Co. LTD. |
| Liang Long | Chasing Securities |
| Xiongwei Jia | China International Capital Corporation Limited |